|
metastatic: search
ABRAXANE share in second line metastatic breast cancer achieves all time high of 42% of the taxane market
in Biological Science
via Nanotechnology News @ 2:11 16th Nov
- Related
The breathing, heart rates and cortisol levels of women with metastatic breast cancer can be used to predict if they'll suffer from chronic insomnia and sleep disruptions, according to a study by scientists at the University of Rochester Medical Center.
in Mobile Technology
via Advance for IRT @ 0:55 26th Oct
- Related
Internal medicine resident Xu Wang, M.D., Ph.D., was debating how to treat a critically ill woman with metastatic ovarian cancer. Should he perform an intubation—an invasive, painful procedure—to prolong her life, even if it would not cure her disease? Or were palliative measures more appropriate? The patient's family, Wang decided, should have the final say, and so he presented them with both options.
in Arts & Culture
via Association of American Medical Colleges @ 15:29 22nd Nov
- Related
ScinoPharm, a supplier of active pharmaceutical ingredients, has received a new US patent, which provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.
in IP & Patents
via Pharmaceutical Business Review @ 16:41 27th Nov
- Related
ScinoPharm, an active pharmaceutical ingredient (API) specialist, has been granted US Patent No. 7,435,818 entitled "Novel Crystal Forms of Irinotecan Hydrochloride." The new patent provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.
in IP & Patents
via PharmaBiz @ 9:09 29th Nov
- Related
PRNewswire-Asia/ -- ScinoPharm, an active pharmaceutical ingredient (API) specialist, announced it has been granted US Patent No. 7,435,818 entitled "Novel Crystal Forms of Irinotecan Hydrochloride." The new patent provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.
in IP & Patents
via Genetic Engineering News @ 11:23 25th Nov
- Related
TAINAN, Taiwan, Nov. 25 /PRNewswire-Asia/ -- ScinoPharm, an active pharmaceutical ingredient (API) specialist, announced it has been granted US Patent No. 7,435,818 entitled "Novel Crystal Forms of Irinotecan Hydrochloride." The new patent provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.
in IP & Patents
via Quamnet @ 11:22 25th Nov
- Related
TAINAN, Taiwan, Nov. 25 /PRNewswire-Asia/ -- ScinoPharm, an active pharmaceutical ingredient (API) specialist, announced it has been granted US Patent No. 7,435,818 entitled "Novel Crystal Forms of Irinotecan Hydrochloride." The new patent provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.
in IP & Patents
via Yahoo! Canada @ 7:02 25th Nov
- Related
TAINAN, Taiwan, November 25, 2008 /PRNewswire-Asia/ -- ScinoPharm, an active pharmaceutical ingredient (API) specialist, announced it has been granted US Patent No. 7,435,818 entitled "Novel Crystal Forms of Irinotecan Hydrochloride." The new patent provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.
in IP & Patents
via Pharma Live @ 11:22 25th Nov
- Related
Search took 0.01 seconds.
|
|